Printer Friendly

FDA Approves Frequent Urination OTC Treatment.

(http://www.fda.gov) The Food and Drug Administration announced the approval of an Over the Counter treatment for frequent urination, also known as overactive bladder. On Friday, Oxytrol was approved for use by women over the age of 18.

The (http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336815.htm) FDA announced its approval of Oxytrol , the first OTC to treat frequent urination on January 25. According to the FDA, overactive bladder is "a condition in which the bladder squeezes too often or squeezes without warning. Symptoms include leaking urine (urinary incontinence), feeling the sudden and urgent need to urinate, and frequent urination. Overactive bladder affects an estimated 33 million Americans, the majority of whom are older women."

Oxytrol works by relaxing the bladder muscle due to the main drug, oxybutynin, which reduces the squeezing and relieve the symptoms of frequent urination. Oxytrol is applied via a patch once every four days which delivers 3.9 milligrams of oxybutynin daily. The FDA said Oxytrol was a safe and effective treatment for overactive bladder.

While women can purchase Oxytrol without a prescription, the same won't be true for men who have frequent urination. Oxytrol will only be available for men by prescription only.

The FDA gave its approval of Oxytrol following the evaluation of nine different studies that involved 5,000 people which determined the treatment was easy to use and the application process was easy to understand. Side effects for Oxytrol during the trials were minimal and included "skin irritation where the patch was applied, dry mouth and constipation."

Oxytrol is manufactured by Merck who plans to release the OTC treatment in the fall, reports (http://news.yahoo.com/fda-oks-over-counter-version-merck-overactive-bladder-163613723--finance.html) Yahoo! . This is the second overactive bladder treatment that has been approved by the FDA in the last two weeks.

On January 18, the (http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm336101.htm) FDA approved Botox injections to treat overactive bladder and frequent urination for individuals who do not respond well to anticholinergics, a class of drugs in which Oxytrol belongs to. Much like Oxytrol, Botox injections will cause the bladder to relax and relieve frequent urination and urinary incontinence. According to Hylton V. Joffe, M.D., director of the Division of Reproductive and Urologic Products in FDA's Center for Drug Evaluation and Research, "Clinical studies have demonstrated Botox's ability to significantly reduce the frequency of urinary incontinence."
COPYRIGHT 2013 International Business Times
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:International Business Times - US ed.
Date:Feb 1, 2013
Words:399
Previous Article:First Video Of Brain Forming Thoughts Captured by Japanese Researchers [VIDEO].
Next Article:Who Is Caleb Moore? A Look Back At X-Games Snowmobile Star And The Accident That Took His Life.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters